TPO agonist 1 |
Katalog-Nr.GC32450 |
TPO-Agonist 1 ist ein Thrombopoietin (TPO)-Agonist, extrahiert aus dem Patent WO2008134338A1, zusammengesetztes TPO-Mimetikum.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1033040-23-1
Sample solution is provided at 25 µL, 10mM.
TPO agonist 1 can increase production of platelets by stimulating the TPO receptor in people with chronic ITP. (Idiopathic Thrombocytopenic Purpura)target: TPO receptor agonist1、TPO receptor agonists can be also used in Bone marrow fibrosis2、TPOreceptor agonists can decrease bleeding events and reduced need for adjunctive or rescue treatments.
[1]. Zeng Y et al. TPO receptor agonist for chronic idiopathic thrombocytopenic purpura. Cochrane Database Syst Rev. 2011 Jul 6;(7):CD008235. [2]. Siegal D et al. Thrombopoietin receptor agonists in primary immune thrombocytopenia. et al. Semin Hematol. 2013 Jan;50 Suppl 1:S18-21
Average Rating: 5
(Based on Reviews and 38 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *